Spirovant Sciences
PrivateLast Round
Grant
Jan 23, 2019
Total Funding Raised
$4.5M
Momentum Score
25 /100
Company Overview
Spirovant Sciences is a biotechnology company that develops gene therapies for cystic fibrosis and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spirovant Sciences Comps
Public and private peers based on sector, stage, and business model.
Spirovant Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 23, 2019 |
Key People
Founding team and executive leadership
Spirovant Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emily's Entourage | Seed |
| Militia Hill Ventures | Seed |
| Cystic Fibrosis Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors increased 63% MoM.
- Jan 20, 2026
Monthly visitors increased 165% MoM.
Spirovant Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spirovant Sciences's valuation, stock price, and market status.
